Effect of Clear Aligner Attachment Size on Extrusion of Maxillary Lateral Incisors
Launched by VIRGINIA COMMONWEALTH UNIVERSITY · Feb 3, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how the size of clear aligner attachments affects the movement of the upper side teeth known as maxillary lateral incisors during orthodontic treatment. Clear aligners, like Invisalign, are a popular alternative to traditional braces because they are more comfortable and less noticeable. The trial aims to understand if different attachment sizes can improve the way these specific teeth move, which is important for achieving the best results in orthodontic treatment.
To participate in the trial, individuals should be at least 12 years old and currently undergoing Comprehensive Invisalign or Invisalign Teen treatment. They must have a certain amount of space between their teeth and meet specific requirements for their maxillary lateral incisors. Participants should also be committed to wearing their aligners as directed throughout the study. Those who join can expect regular check-ins and assessments to monitor their progress. This trial is currently recruiting participants, so it's a great opportunity for those looking to optimize their orthodontic experience with clear aligners.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients treated with either Comprehensive Invisalign or Invisalign Teen treatment
- • The maxillary arch has less than 6 mm of crowding or spacing
- • Maxillary lateral incisors have a minimum of 0.3 mm of extrusion prescribed in the Tooth Movement Table on the Invisalign ClinCheck for the first set of aligners
- • Maxillary lateral incisors within a normal range of bucco-lingual inclination
- • Patients 12 years of age or older and either the patient or legal guardian are able to give consent
- • Patients confirm good compliance throughout the study period
- Exclusion Criteria:
- • Patients do not complete all aligners in the first phase as prescribed
- • Poor compliance recorded for aligner wear
- • Restorations placed or oral surgery completed prior to final scan
- • Midcourse intervention to improve tracking such as a bootstrap
- • Maxillary lateral incisors not tracking and noted by minimum of 1 mm of aligner material incisally displaced when aligner fully seated
- • Treatment plans include surgery or extractions
- • Maxillary lateral incisors with pathology and restorations
- • Missing teeth other than third molars
- • Patients with anterior crossbite
About Virginia Commonwealth University
Virginia Commonwealth University (VCU) is a prominent academic institution and research leader located in Richmond, Virginia. Renowned for its commitment to advancing healthcare through innovative research and education, VCU plays a pivotal role in clinical trials aimed at improving patient outcomes and understanding complex health issues. The university boasts a collaborative environment, leveraging its diverse faculty expertise and state-of-the-art facilities to conduct rigorous clinical research across various medical disciplines. VCU's dedication to ethical research practices and community engagement ensures that its clinical trials are designed to address critical health challenges while prioritizing participant safety and well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Richmond, Virginia, United States
Patients applied
Trial Officials
Steven Lindauer
Principal Investigator
Virginia Commonwealth University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported